Inventor
WACKER DEAN A
US49 patents
⚠️ This page may combine multiple inventors who share the name “WACKER DEAN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB PHARMA CO
20 patentsUS6525069B1Feb 25, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO52 citations95
US6949546B2Sep 27, 2005
N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO18 citations92
US6759411B2Jul 6, 2004
Heterocyclic piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO26 citations92
US6638950B2Oct 28, 2003
Piperidine amides as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO36 citations92
US6605623B1Aug 12, 2003
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO36 citations92
US6441001B1Aug 27, 2002
2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO26 citations92
US6492400B1Dec 10, 2002
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO15 citations84
US6864380B2Mar 8, 2005
Benzylcycloalkyl amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO5 citations74
US6780857B2Aug 24, 2004
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO6 citations73
US6486180B1Nov 26, 2002
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO10 citations72
US7126010B2Oct 24, 2006
Benzylcycloalkyl amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6984651B2Jan 10, 2006
Piperidine amides as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations63
US6960666B2Nov 1, 2005
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6784200B2Aug 31, 2004
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO4 citations63
US6706735B2Mar 16, 2004
2-substituted-4-nitrogen heterocycles as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations63
US6919368B2Jul 19, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations62
US6906066B2Jun 14, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations61
US6875776B2Apr 5, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations61
US6897234B2May 24, 2005
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO3 citations55
US7312222B2Dec 25, 2007
Heterocyclic piperidines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
BRISTOL MYERS SQUIBB CO
16 patentsUS7928230B2Apr 19, 2011
Method for modulating GPR119 G protein-coupled receptor and selected compounds
BRISTOL MYERS SQUIBB CO10 citations84
US6586446B1Jul 1, 2003
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO8 citations74
US11713312B2Aug 1, 2023
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US11254663B2Feb 22, 2022
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO2 citations70
US8513265B2Aug 20, 2013
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
BRISTOL MYERS SQUIBB CO1 citations63
US8372837B2Feb 12, 2013
Pyridone and pyridazone analogues as GPR119 modulators
BRISTOL MYERS SQUIBB CO3 citations63
US8003796B2Aug 23, 2011
Pyridone GPR119 G protein-coupled receptor agonists
BRISTOL MYERS SQUIBB CO3 citations63
US7910583B2Mar 22, 2011
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
BRISTOL MYERS SQUIBB CO2 citations63
US7244843B2Jul 17, 2007
Modulators of serotonin receptors
BRISTOL MYERS SQUIBB CO3 citations58
US7550500B2Jun 23, 2009
Bicyclic and tricyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations52
US9174965B2Nov 3, 2015
Pyrimidinylpiperidinyloxypyridone analogues as GPR119 modulators
BRISTOL MYERS SQUIBB CO0 citations50
US12319676B2Jun 3, 2025
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations48
US12030835B2Jul 9, 2024
Substituted amide compounds useful as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations47
US12227496B2Feb 18, 2025
Substituted bicyclic compounds as farnesoid X receptor modulators
BRISTOL MYERS SQUIBB CO0 citations46
US7230022B2Jun 12, 2007
Substituted fused bicyclic amines as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations42
US7479496B2Jan 20, 2009
Substituted spiro azabicyclics as modulators of chemokine receptor activity
BRISTOL MYERS SQUIBB CO0 citations41
FEVIG JOHN M
4 patentsUS8314095B2Nov 20, 2012
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
FEVIG JOHN M1 citations61
US8476283B2Jul 2, 2013
[6,5]—bicyclic GPR119 G protein-coupled receptor agonists
FEVIG JOHN M0 citations50
US8093257B2Jan 10, 2012
[6,5]-bicyclic GPR119 G protein-coupled receptor agonists
FEVIG JOHN M1 citations50
US8076322B2Dec 13, 2011
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
FEVIG JOHN M0 citations50
WACKER DEAN A
3 patentsUS8232404B2Jul 31, 2012
Pyridone GPR119 G protein-coupled receptor agonists
WACKER DEAN A2 citations60
US8513424B2Aug 20, 2013
Pyridone GPR119 G protein-coupled receptor agonists
WACKER DEAN A0 citations50
US8178561B2May 15, 2012
Method for modulating GPR119 G protein-coupled receptor and selected compounds
WACKER DEAN A0 citations50